Literature DB >> 17632285

The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.

Luciana Ribeiro1, João V Busnello, Rita M Cantor, Fiona Whelan, Pamela Whittaker, Panos Deloukas, Ma-Li Wong, Julio Licinio.   

Abstract

The hypothesis that brain-derived neurotrophic factor (BDNF) is involved in the pathogenesis of major depression is supported by several research findings; however, genetic studies assessing the relationship between BDNF and psychiatric disorders have produced conflicting results. We examined the effect of a BDNF polymorphism on depression susceptibility in Mexican-Americans. The single nucleotide polymorphism (Val66Met), which has been shown to have functional and behavioral effects, was genotyped in 284 depressed participants and 331 controls, showing association with depression (P=0.005). Individuals homozygous for the major allele (GG) had an increased chance of being depressed (OR=1.7 95% CI 1.17-2.47). Our findings support the association of BDNF single nucleotide polymorphism rs6265 and depression, suggesting that this polymorphism may increase susceptibility to major depression in Mexican-Americans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632285      PMCID: PMC2686836          DOI: 10.1097/WNR.0b013e328273bcb0

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

1.  Highly parallel SNP genotyping.

Authors:  J B Fan; A Oliphant; R Shen; B G Kermani; F Garcia; K L Gunderson; M Hansen; F Steemers; S L Butler; P Deloukas; L Galver; S Hunt; C McBride; M Bibikova; T Rubano; J Chen; E Wickham; D Doucet; W Chang; D Campbell; B Zhang; S Kruglyak; D Bentley; J Haas; P Rigault; L Zhou; J Stuelpnagel; M S Chee
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2003

2.  Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

Authors:  B Chen; D Dowlatshahi; G M MacQueen; J F Wang; L T Young
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

3.  Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

Authors:  J A Siuciak; D R Lewis; S J Wiegand; R M Lindsay
Journal:  Pharmacol Biochem Behav       Date:  1997-01       Impact factor: 3.533

4.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

Authors:  Félicien Karege; Guillaume Perret; Guido Bondolfi; Michèle Schwald; Gilles Bertschy; Jean-Michel Aubry
Journal:  Psychiatry Res       Date:  2002-03-15       Impact factor: 3.222

5.  Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

Authors:  Yukihiko Shirayama; Andrew C-H Chen; Shin Nakagawa; David S Russell; Ronald S Duman
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

6.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

Authors:  M Nibuya; S Morinobu; R S Duman
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

7.  Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.

Authors:  Chen-Jee Hong; Sheue-Jane Huo; Feng-Chang Yen; Chun-Liang Tung; Guo-Mei Pan; Shih-Jen Tsai
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

8.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

Review 9.  Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: evidence, limitations, and implications.

Authors:  Elaine Green; Nick Craddock
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

10.  No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults.

Authors:  Paul G Surtees; Nicholas W J Wainwright; Saffron A G Willis-Owen; Manjinder S Sandhu; Robert Luben; Nicholas E Day; Jonathan Flint
Journal:  J Psychiatr Res       Date:  2006-02-23       Impact factor: 4.791

View more
  36 in total

1.  Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus.

Authors:  Aysun Coskunoglu; Seda Orenay-Boyacioglu; Artuner Deveci; Mustafa Bayam; Ece Onur; Arzu Onan; Fethi S Cam
Journal:  Noise Health       Date:  2017 May-Jun       Impact factor: 0.867

2.  Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.

Authors:  Clement C Zai; Mirko Manchia; Ida Elken Sønderby; Zeynep Yilmaz; Vincenzo De Luca; Arun K Tiwari; Alessio Squassina; Gwyneth C Zai; Sajid A Shaikh; John Strauss; Nicole King; Bernard Le Foll; Allan S Kaplan; Per I Finseth; Arne E Vaaler; Srdjan Djurovic; Ole A Andreassen; John B Vincent; James L Kennedy
Journal:  World J Biol Psychiatry       Date:  2014-09-29       Impact factor: 4.132

3.  Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms.

Authors:  Rong Jiang; Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Redford B Williams
Journal:  J Psychiatr Res       Date:  2012-11-08       Impact factor: 4.791

4.  Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.

Authors:  Jerome H Taylor; Angeli Landeros-Weisenberger; Catherine Coughlin; Jilian Mulqueen; Jessica A Johnson; Daniel Gabriel; Margot O Reed; Ewgeni Jakubovski; Michael H Bloch
Journal:  Neuropsychopharmacology       Date:  2017-08-29       Impact factor: 7.853

5.  Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.

Authors:  Renata Suchanek; Aleksander Owczarek; Małgorzata Kowalczyk; Krzysztof Kucia; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2010-11-20       Impact factor: 3.444

6.  Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

Authors:  Gonzalo Laje; Roy H Perlis; A John Rush; Francis J McMahon
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

Review 7.  Genetics Factors in Major Depression Disease.

Authors:  Maria Shadrina; Elena A Bondarenko; Petr A Slominsky
Journal:  Front Psychiatry       Date:  2018-07-23       Impact factor: 4.157

8.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

9.  Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.

Authors:  Julio Licinio; Chuanhui Dong; Ma-Li Wong
Journal:  Arch Gen Psychiatry       Date:  2009-05

10.  Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression.

Authors:  Wu Hong; Jinbo Fan; Chengmei Yuan; Chen Zhang; Yingyan Hu; Daihui Peng; Yong Wang; Jia Huang; Zezhi Li; Shunying Yu; Xiaohua Liu; Zhiguo Wu; Jun Chen; Zhenghui Yi; Lin Xu; Yiru Fang
Journal:  Neuroreport       Date:  2014-07-09       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.